| Testing endothelial function and its clinical relevance P Poredos, MK Jezovnik Journal of atherosclerosis and thrombosis 20 (1), 1-8, 2013 | 185 | 2013 |
| The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis P Poredos, MK Jezovnik International angiology 26 (4), 306, 2007 | 147 | 2007 |
| Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction MK Jezovnik, P Poredos International Angiology 29 (3), 226, 2010 | 95 | 2010 |
| Endothelial dysfunction and venous thrombosis P Poredos, MK Jezovnik Angiology 69 (7), 564-567, 2018 | 90 | 2018 |
| Do blood constituents in varicose veins differ from the systemic blood constituents? P Poredos, A Spirkoska, T Rucigaj, J Fareed, MK Jezovnik European Journal of Vascular and Endovascular Surgery 50 (2), 250-256, 2015 | 70 | 2015 |
| Markers of preclinical atherosclerosis and their clinical relevance P Poredoš, MK Ježovnik Vasa 44 (4), 247-256, 2015 | 67 | 2015 |
| Patients with an inflamed atherosclerotic plaque have increased levels of circulating inflammatory markers P Poredos, A Spirkoska, L Lezaic, MB Mijovski, MK Jezovnik Journal of Atherosclerosis and Thrombosis 24 (1), 39-46, 2017 | 62 | 2017 |
| In patients with idiopathic venous thrombosis, interleukin-10 is decreased and related to endothelial dysfunction P Poredos, MK Jezovnik Heart and vessels 26, 596-602, 2011 | 55 | 2011 |
| Rivaroxaban versus warfarin in the prevention of post-thrombotic syndrome L Jeraj, MK Jezovnik, P Poredos Thrombosis research 157, 46-48, 2017 | 50 | 2017 |
| Idiopathic venous thrombosis is associated with preclinical atherosclerosis MK Jezovnik, P Poredos, L Lusa Journal of Atherosclerosis and Thrombosis 17 (3), 304-311, 2010 | 42 | 2010 |
| Factors influencing the recanalisation rate of deep venous thrombosis. MK Jezovnik, P Poredos International angiology: a journal of the International Union of Angiology …, 2012 | 39 | 2012 |
| Dyslipidemia, statins, and venous thromboembolism P Poredos, MK Jezovnik Seminars in thrombosis and hemostasis 37 (08), 897-902, 2011 | 36 | 2011 |
| Structure of atherosclerotic plaques in different vascular territories: clinical relevance P Poredos, P Poredos, MK Jezovnik Current Vascular Pharmacology 16 (2), 125-129, 2018 | 35 | 2018 |
| Infrapopliteal run-off and the outcome of femoropopliteal percutaneous transluminal angioplasty V Salapura, A Blinc, M Kozak, MK Jezovnik, M Pohar Perme, P Berden, ... Vasa 39 (2), 159-168, 2010 | 31 | 2010 |
| The role of inflammatory biomarkers in the detection and therapy of atherosclerotic disease P Poredos, M K Jezovnik Current vascular pharmacology 14 (6), 534-546, 2016 | 30 | 2016 |
| Patients with a history of idiopathic deep venous thrombosis have long-term increased levels of inflammatory markers and markers of endothelial damage MK Jezovnik, J Fareed, P Poredos Clinical and Applied Thrombosis/Hemostasis 23 (2), 124-131, 2017 | 28 | 2017 |
| Time course and the recanalization rate of superficial vein thrombosis treated with low-molecular-weight heparin A Spirkoska, MK Jezovnik, P Poredos Angiology 66 (4), 381-386, 2015 | 27 | 2015 |
| In patients with superficial vein thrombosis the inflammatory response is increased and related to the recanalization rate P Poredoš, A Spirkoska, MK Ježovnik Archives of Medical Science 15 (2), 393-401, 2019 | 26 | 2019 |
| Is aspirin still the drug of choice for management of patients with peripheral arterial disease P Poredos, MK Jezovnik Vasa 42 (2), 88-95, 2013 | 26 | 2013 |
| Impairment of the vasodilatation capability of the brachial artery in patients with idiopathic venous thrombosis MK Jezovnik, P Poredos, M Stalc Journal of Atherosclerosis and Thrombosis 17 (11), 1190-1198, 2010 | 26 | 2010 |
Pier Luigi Antignanidirettore centro vascolare villa claudiaVerified email at mclink.it
